Swiss - Delayed Quote CHF
Newron Pharmaceuticals S.p.A. (NWRN.SW)
8.24
+0.22
+(2.74%)
At close: May 9 at 5:31:16 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
63,908
25,866
37,195
50,486
Total Liabilities Net Minority Interest
62,450
55,774
51,225
47,379
Total Equity Gross Minority Interest
1,458
-29,908
-14,030
3,107
Total Capitalization
37,701
-4,155
31,135
45,649
Common Stock Equity
1,458
-29,908
-14,030
3,107
Capital Lease Obligations
812
385
497
539
Net Tangible Assets
1,458
-29,908
-14,030
3,105
Working Capital
37,598
-9,274
23,452
35,773
Invested Capital
51,115
18,122
31,135
45,649
Tangible Book Value
1,458
-29,908
-14,030
3,105
Total Debt
50,469
48,415
45,662
43,081
Net Debt
42,724
41,692
31,741
17,523
Share Issued
19,958.86
17,845.35
17,845.35
17,845.35
Ordinary Shares Number
19,958.86
17,845.35
17,845.35
17,845.35
12/31/2021 - 12/11/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XLS.SW Xlife Sciences AG
20.50
-2.84%
MOLN.SW Molecular Partners AG
3.4400
+2.23%
SANN.SW Santhera Pharmaceuticals Holding AG
13.18
-0.15%
IDIA.SW Idorsia Ltd
1.2820
-2.88%
ONESOURCE.BO OneSource Specialty Pharma Limited
1,585.30
-0.97%
HPHA.DE Heidelberg Pharma AG
3.1400
-0.95%
0OIR.IL ALK-Abelló A/S
149.45
0.00%
0RQE.IL Idorsia Ltd
1.2820
-2.51%
BSLNz.XC
22Z.BE Zealand Pharma A/S
57.42
+1.16%